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EDITORIAL 
The Immunopathogenesis of Dermatitis Herpetiformis 
During the past two decades, the pace of research into t he 
pathogenes is of dermatitis herpetiformis (DH) has quickened. 
The first 80 yea rs after t he original description of DH by 
Duhring in 1884 [1] were marked by further characterization 
of t he clin ical di sease, an appreciation of the therapeutic value 
of sulfapyridine and su lfones in t he 1940s and 1950s (2], and 
accurate accounts of the hi stopathologic features of DH in 1890 
[3] and again in t he early 1960s [4,5 ]. Since t he mid-1960s, 
three major observations have stimulated t he interest of inves-
t igative dermatologists in this disease: (1) t he association of 
DH with specific histocompatibili ty antigens [6, 7], (2) t he 
description of a gluten-sensit ive enteropathy (GSE) in DH 
patients [8], and (3) the discovery of granular IgA deposits in 
t he skin of DH patients [9,10] . Although some of the pieces of 
t he puzzle relative to the immunopathogenes is of DH are now 
beginning to fall in to place, several cri t ica l aspects of the DH 
puzzle still must be solved. 
Genetic susceptibility, an aspect of DH that is now becoming 
clear, is marked by an increased frequency of HLA types B-8, 
DR3, and a new OR-related antigen, Te24 [6,7,11]. T he strong 
associat ion with DR haplotypes implies that disease suscepti-
b ility may be determined by specific immune response genes 
t hat are closely linked to t hese HLA ant igens. Those HLA 
types t hat occur with increased freq uency in DH are not specific 
fo r t his di sease but tend to be associated with other diseases 
w ith unusual immune reactivity, such as systemic lupus erythe-
matosus, subacute cutaneous lupus erythematosus, sicca syn-
drome, Graves' disease, and myasthenia gravis [1 2,13]. It ap-
pears therefore that one component of t he genetic susceptibili ty 
to DH may be immu nologic hyperreactivity. In support of this 
hypothes is, other immunologically mediated diseases, including 
thyroid disease, lupus erythematosus, and atopy, may occur 
w ith increased frequency in patients with DH [14,15], and t here 
appears to be an unusual frequency in DH patients of certain 
autoantibodies including antit hyroid and antinuclear ant ibod-
ies [16,17]. 
A second major piece of t he DH puzz le t hat seems secure is 
immunologic reactivity to dietary antigens, specifica lly to wheat 
protein ant ige ns. DH appears to occur in a subset of immuno-
logically reactive individuals who a re predisposed to react to 
w heat prote in and to develop GSE. Facts supporting t his t hesis 
include t he occurrence of simila r HLA profiles in patients with 
symptomatic GSE and those with DH [6,7, 11], t he occurrence 
of symptomatic GSE and DH in t he same family and occasion-
a lly in t he same individual [18,19], the presence of histo logic 
evidence of enteropathy, although often subt le, in most DH 
patients [8], the presence of circulating antibodies t hat react 
w ith wheat protein in bot h GSE and DH patients [20,21], and 
the response of both GSE and DH to a strict gluten-free diet 
[22,23]. Current t hinking is that reactiv ity to wheat protein is 
more t han a nonspecific phenomenon in DH and represents a 
critical factor in the genesis of t he skin disease. 
The greatest difticul ty in understanding the pathogenes is of 
DH is in explaining how immune hyperreactivity and immune 
reactivi ty to wheat protein are related to t he t hird major 
discove ry, the deposition of granular IgA in the papillary dermis 
and along the basement membrane zone of t he sk in. The IgA 
deposit ion in DH skin is so distinctive and specifi c [24,25] that 
th is find ing must be centra l to t he evo lution of the inflamma-
tory skin disease rather t han a nonspecific epiphenomenon. 
Evidence of t he potent ia l pathogenetic significance of t he IgA 
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deposits includes the presence of t he deposits in the uninvolved 
skin where t he rash ofDH may occur [9,10,25] and the presence 
along with the IgA deposits of complement components [25,26] 
which may lead to t he ingress and activation of neutrophils. A 
recent fascinating observation is t hat DH patients in remission 
on a strict gluten-free diet may lose t he IgA deposits in t he 
skin and that the IgA deposits return along with the clinical 
disease when a normal gluten-containing diet is resumed 
[27]. These observations point to t he cutaneous IgA deposits 
as t he crit ical link between sensit ivity to dietary wheat protei n 
and the inflammato ry skin disease. 
To most investigators it has been plausible that the "DH 
factor ," that is, t he factor t hat determines the occurrence of 
skin disease in gluten-sensit ive individuals, is some abnormal-
ity or immunopathogenetic mechanism which involves IgA 
[25,28). Several hypotheses have been proposed for the DH 
facto r. One study proposed that ant ibodies to small connective 
t issue fibers or reticulin may cross react with wheat protein 
(29). This findin g has not been confirmed, and there is litt le 
supporting evidence for the role of any IgA autoantibodies in 
the immu nopathogenesis of DH [28]. A second hypothesis is 
t hat circulating immune complexes involving IgA lead to t he 
cutaneous IgA deposits. In support of t his theory are positive 
Raji ce ll IgA immune complex assays of DH sera (28,30,31 ) and 
evidence t hat the reticuloendothelial system of DH pat ients 
may not clea r immune complexes in a normal manner (32]. 
However , the circulating immune complex t heory has not been 
total ly satisfactory: the granular IgA sta ining in DH skin is not 
in the blood vessels, as occurs with a circulating immune 
complex injury; histologic evidence of a vascular insult is usu-
ally absent, both in t he skin and in other orga n systems; and 
pertinent ant igens, such as wheat protein antigens, have not 
been detected along with the IgA deposits [25,28). Another 
possibility that has not been t horoughly investigated is whether 
basic defects in IgA production and metabolism might exist in 
DH patients. Serum IgA levels tend to be elevated in DH 
[33,34] and specific IgA antibodies to gluten are elevated above 
those of GSE patients without DH [21]. No matter which 
hypothesis is being considered, however, the question t hat has 
never been adequately explained is why IgA, which may arise 
from the lymphoid t issue associated with the gastrointestinal 
t ract and respiratory t ract or from t he bone marrow, localizes 
in t he skin in DH. 
In an attempt to better understand the cutaneous IgA depos-
its of DH, many investigators have focused t heir research 
efforts on characterization of t hese deposits. By immunoelec-
t ron microscopy, the IgA deposits are localized just beneath the 
basal lamina closely associated with fibri ll ar structures, which 
have been termed microfibrillary bundles [35-37]. By immu-
nofluorescence staining, t he lgA deposits contain J chain 
whic h marks t he presence of at least some amount of dimeri~ 
lgA r3s]. In addition, the IgA is polyclonal and secretory 
component is absent [25,38]. 
A major hindrance to the study of the IgA deposits in DH 
sk in has been the inab ili ty of investigators to extract the IgA 
from DH skin biopsies. Katz and Strober [25] and other inves-
tigators have noted the insolubil ity of these deposits. The first 
report that the IgA could be released from the skin deposits 
was t hat of Egelrud and Back in 1984 [39]. These researchers 
used a unique method fo r isolati ng small samples of papillary 
dermis and demonstrated that digestion by pepsin, but not by 
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trypsi n, collagenase, or elastase, caused a remarkable loss of 
t he IgA deposits, as detected by immunoflu orescence, and re-
leased immunoreactive lgA into t he supernatant. 
In t his issue of The Journal of Investigative Dermatology, 
t hese same authors have expanded their original observations 
and report extraction of IgA from DH skin by two methods, 
with t he detergent sodium dodecyl sulfate (SDS) and by pepsin 
digestion. By use of radio iodinated samples of papillary dermis, 
immunoprecipitation, and autoradiograp hy, t hey have demon-
strated immunoreactive IgA in extracts of DH skin. The SDS-
extracted IgA consisted of monomers, dimers, and high-molec-
ular-weight polyme rs. The high-molecular-weight lgA material 
could not be eas ily degraded into smaller peptides and was 
thought to be irreversibly aggregated. Despite the use of ex-
tremely sens it ive tech niques and a method of pepsin digestion 
that should preserve antigen-antibody bonds, t hese investiga-
tors were unable to identify ant igens to which t he lgA might 
be bound. T he authors further suggest t hat t he effectiveness in 
release of lgA of pepsin digestion at pH 4.5, a technique that 
fragments t he Fe portion of immu noglobulin , may be compat-
ible with the binding of t he lgA in the skin by the Fe portion 
of the mo lecule. 
The implicat ions of th is work by Egelrud and Back fo r DH 
research are high ly significant. Now, for t he first t ime, the 
antige nic specificity of t he cutaneous lgA may be studied, and 
the binding of t he extracted lgA into DH and normal skin may 
be evaluated. T he techn iques described in t his paper wi ll be a 
sign ificant contribution to understanding of t he mechanism of 
l gA depos ition in the skin and may help to solve th is critical 
segment of the DH puzzle. 
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